> Details

Lapuente, Dennis; Fuchs, Jana; Willar, Jonas; Vieira Antão, Ana; Eberlein, Valentina; Uhlig, Nadja; Issmail, Leila; Schmidt, Anna; Oltmanns, Friederike; Peter, Antonia Sophia; Mueller-Schmucker, Sandra; Irrgang, Pascal; Fraedrich, Kirsten; Cara, Andrea; Hoffmann, Markus; Pöhlmann, Stefan; Ensser, Armin; Pertl, Cordula; Willert, Torsten; Thirion, Christian; Grunwald, Thomas; Überla, Klaus; Tenbusch, Matthias

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
  • Contributor: Lapuente, Dennis; Fuchs, Jana; Willar, Jonas; Vieira Antão, Ana; Eberlein, Valentina; Uhlig, Nadja; Issmail, Leila; Schmidt, Anna; Oltmanns, Friederike; Peter, Antonia Sophia; Mueller-Schmucker, Sandra; Irrgang, Pascal; Fraedrich, Kirsten; Cara, Andrea; Hoffmann, Markus; Pöhlmann, Stefan; Ensser, Armin; Pertl, Cordula; Willert, Torsten; Thirion, Christian; Grunwald, Thomas; Überla, Klaus; Tenbusch, Matthias
  • Published: Springer Science and Business Media LLC, 2021
  • Published in: Nature Communications, 12 (2021) 1
  • Language: English
  • DOI: 10.1038/s41467-021-27063-4
  • ISSN: 2041-1723
  • Origination:
  • Footnote:
  • Description: AbstractSeveral effective SARS-CoV-2 vaccines are currently in use, but effective boosters are needed to maintain or increase immunity due to waning responses and the emergence of novel variants. Here we report that intranasal vaccinations with adenovirus 5 and 19a vectored vaccines following a systemic plasmid DNA or mRNA priming result in systemic and mucosal immunity in mice. In contrast to two intramuscular applications of an mRNA vaccine, intranasal boosts with adenoviral vectors induce high levels of mucosal IgA and lung-resident memory T cells (TRM); mucosal neutralization of virus variants of concern is also enhanced. The mRNA prime provokes a comprehensive T cell response consisting of circulating and lung TRM after the boost, while the plasmid DNA prime induces mostly mucosal T cells. Concomitantly, the intranasal boost strategies lead to complete protection against a SARS-CoV-2 infection in mice. Our data thus suggest that mucosal booster immunizations after mRNA priming is a promising approach to establish mucosal immunity in addition to systemic responses.
  • Access State: Open Access